Summary
The focus of this review article is on the novel and challenging concepts that have emerged in the field of gastroesophageal reflux disease (GERD) and Barrett’s esophagus over the recent years. Lenglinger et al. (Wien Klin Wochenschr. 2013;125:577–590) have made an in-depth PubMed research on studies dealing with histopathology of nondysplastic columnar lined esophagus (CLE). The aim of the review is to summarize the current body of knowledge regarding the pathophysiology of nondysplastic CLE and its implications for the diagnosis and treatment of this pre-neoplastic condition.
References
Lenglinger J, Fischer See S, Beller L, et al. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr. 2013;125:577–90.
Chandrasoma P, Wijetunge S, Ma Y, et al. The dilated distal esophagus: a new entity that is the pathologic basis of early gastroesophageal reflux disease. Am J Surg Pathol. 2011;35:1873–81.
Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997;226:522–32.
Allison PR, Johnstone AS. The esophagus lined with gastric mucous membrane. Thorax. 1953;8:87.
Barrett NR. Chronic peptic ulcer of the oesophagus and “oesophagitis”. Br J Surg. 1950;38:175–82.
Chandrasoma PT, DeMeester TR. GERD. Reflux to esophageal adenocarcinoma. Elsevier Academic Press, 2006.
Fischer See S, Schoppmann SF, Riegler M, Zacherl J. Radiofrequency ablation and antireflux management for non-dysplastic Barrett’s esophagus. In: Bonavina L, editor. Innovation in esophageal surgery. Italia: Springer-Verlag; 2012. pp. 27–41.
Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.
Gurski R, Peters JH, Hagen JA, et al. Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive factors. J Am Coll Surg. 2003;196:706–12.
Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.
Martinez de Haro LF, Ortiz A, Parrilla P, et al. Long-term follow-up of malignancy biomarkers in patients with Barrett’s esophagus undergoing medical or surgical treatment. AnnSurg. 2012;255:916–21.
Souza R, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776–84.
Huo X, Zhang HY, Zhang X, et al. Acid and bile salt induced CDX 2 expression differs in squamous cells from patients with and without Barrett’s esophagus. Gastroenterology. 2010;139:194–203.
Riegler FM. Respond as reflux dials CDX2. Eur Surg. 2010;42:69–71.
Author information
Authors and Affiliations
Corresponding author
Additional information
Source: Lenglinger J, Fischer See S, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF, Wien Klin Wochenschr. 2013;125:577–590.
Rights and permissions
About this article
Cite this article
Bonavina, L. Selected commentary to review on novel concepts of columnar lined esophagus. Eur Surg 46, 96–97 (2014). https://doi.org/10.1007/s10353-014-0260-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10353-014-0260-1